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Predictors and Clinical Impact of Inappropriate Implantable 
Cardioverter-Defibrillator Shocks in Korean Patients 
Limited data are available on inappropriate shocks in Korean patients implanted with an 
implantable cardioverter-defibrillator (ICD). We investigated the impact of inappropriate 
shocks on clinical outcomes. This retrospective, single-center study included 148 patients 
treated between October 1999 and June 2011. The primary outcome was a composite 
event of all-cause mortality or hospitalization for any cardiac reason. The median follow-
up duration was 29 months (interquartile range: 8 to 53). One or more inappropriate 
shocks occurred in 34 (23.0%) patients. A history of atrial fibrillation was the only 
independent predictor of inappropriate shock (hazard ratio [HR]: 4.16, 95% confidence 
interval [CI]: 1.89-9.15, P < 0.001). Atrial fibrillation was the most common cause of 
inappropriate shock (67.7%), followed by supraventricular tachycardia (23.5%), and 
abnormal sensing (8.8%). A composite event of all-cause mortality or hospitalizations for 
any cardiac reason during follow-up was not significantly different between patients with 
or without inappropriate shock (inappropriate shock vs no inappropriate shock: 35.3% vs 
35.4%, adjusted HR: 1.06, 95% CI: 0.49-2.29, P = 0.877). Inappropriate shocks do not 
affect clinical outcomes in patients implanted with an ICD, although the incidence of 
inappropriate shocks is high.
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Cardiovascular Disorders
INTRODUCTION 
Implantable cardioverter-defibrillator (ICD) therapy reduces 
mortality in survivors of sudden cardiac arrest and patients at 
high risk for cardiovascular disease (1-5). Despite the proven 
survival benefits of an ICD, a common adverse effect is inap-
propriate shocks. Inappropriate shocks occur following atrial 
arrhythmias with rapid ventricular conduction or sensing errors 
and can be painful, impair the quality of life, cause psychiatric 
disturbances, and be potentially arrhythmogenic (6, 7). Recent 
studies on the relationship between inappropriate shocks and 
clinical outcomes have shown mixed results (8, 9). Therefore, 
we investigated the impact of inappropriate shock on long-term 
clinical outcomes in patients implanted with an ICD as primary 
and secondary prevention of sudden cardiac death.
MATERIALS AND METHODS
Study population 
The medical records of 148 patients implanted with an ICD be-
tween October 1999 and June 2011 at Samsung Medical Center 
in Seoul, Korea were analyzed retrospectively. Any additional 
information was collected by contacting general practitioners, 
reviewing hospital records, and conducting telephone interviews. 
The primary outcome was a composite event of all-cause mor-
tality or hospitalization for cardiac causes. The secondary out-
come was all-cause mortality during follow-up.
ICD implantation 
The indication for ICD implantation was secondary prevention 
in patients who had experienced aborted sudden cardiac death, 
sustained ventricular tachyarrhythmia, or presumed tachyar-
rhythmic syncopal attacks. The indication for ICD implantation 
in all other patients was primary prevention. All defibrillator 
systems were implanted in the pectoral region. The ICDs were 
manufactured by St. Jude Medical, Inc. (St. Paul, MN, USA), 
Medtronic, Inc (Minneapolis, MN, USA) or Guidant Corp (Indi-
anapolis, IN, USA). We often attempted to tailor the therapy 
based on electrophysiology studies, a patient’s arrhythmia his-
tory, or both (patient-specific tailored programming). The ICDs 
can be programmed to provide different therapies for tachyar-
rhythmias in up to three heart rate zones. The ICD can deliver 
bursts of antitachycardia pacing, cardioversion, or defibrillation 
in each therapy zone. Although a variety of algorithms exist,  
antitachycardia pacing was usually delivered at a slightly faster 
rate (a cycle length 10% to 12% shorter) than the rate of the de-Yang JH, et al.  •  Predictors and Clinical Impact of Inappropriate Shock
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tected tachycardia. Devices often delivered synchronized car-
dioversion for tachyarrhythmias in this range (heart rate below 
160 or 180 beats/min), and usually delivered unsynchronized 
shocks for very rapid ventricular arrhythmias (heart rate  > 180 
or 200 beats/min). Furthermore, most devices offered 3 algo-
rithms intended to minimize inappropriate shocks: 1) “stabili-
ty”, detecting irregularity in cycle length of the tachyarrhythmia; 
2) “sudden onset”, monitoring the cycle length for the sudden 
or abrupt onset of a high ventricular rate rather than a gradually 
increasing heart rate (10); and 3) “QRS morphology”, compar-
ing the electrograms during the tachycardia to the baseline QRS 
shape, duration, and polarity. The dual-chamber devices pro-
vided additional algorithms evaluating the atrial rate (11). The 
ICD programming, including such discriminator usage, was left 
to the discretion of the operators.
Follow-up 
After ICDs were implanted, patients were followed in our out-
patient ICD clinic. The devices were interrogated, and the com-
plete data set (including intracardiac electrograms) was record-
ed. The delivered therapy was adjudicated by a trained electro-
physiologist. Appropriate ICD therapy was defined as either car-
dioversion, defibrillation of ventricular tachycardia (VT), or de-
fibrillation of ventricular fibrillation (VF) based on the stored 
electrogram. An inappropriate shock was defined as an episode, 
starting with a shock not delivered for VT or VF and ending when 
the ICD detected sinus rhythm. The rhythm triggering therapy 
was categorized as atrial fibrillation or atrial flutter, supraven-
tricular including sinus tachycardia, or abnormal sensing. 
Statistical analysis
All values are presented as the mean ± standard deviation or 
median with interquartile range. Comparisons between con-
tinuous variables were tested using the t-test or Mann-Whitney 
U test, as appropriate. Categorical data were tested using the 
chi-square test or Fisher’s exact test, as appropriate. Event-free 
survival was estimated by the Kaplan-Meier method and com-
pared using the log-rank test. Adjusted hazard rates were com-
pared by multivariable Cox proportional-hazards regression 
analysis. Covariates that were statistically significant by univari-
ate analysis or that were clinically relevant were considered can-
didate variables for the multivariate models. The relationship 
between inappropriate shocks and clinical outcomes was as-
sessed using a Cox proportional-hazards model adjusting for 
the following covariates: age  > 70 yr, previous coronary bypass 
surgery, history of atrial fibrillation, left ventricular ejection frac-
tion  < 40%, serum creatinine  ≥ 1.5 (mg/dL), interim appropri-
ate shocks, interim inappropriate shocks, and device type. All 
tests were two-tailed, and P < 0.05 was considered statistically 
significant. All analyses were performed with SPSS software ver-
sion 18.0 (SPSS Inc., Chicago, IL, USA).
Ethics statement
The institutional review board at Samsung Seoul Hospital ap-
proved this study (IRB No. 2009-09-047). All of subjected patients 
gave written informed consent for the ICD implantation proce-
dure. 
RESULTS
Baseline characteristics and etiology of inappropriate 
shocks 
A total of 148 patients with an ICD were identified from the ICD 
database at Samsung Medical Center. Of these, 34 (23.0%) pa-
tients experienced one or more episodes of inappropriate ICD 
shocks. Baseline clinical characteristics are provided in Table 1. 
Overall, 34 patients were implanted with an ICD for primary pre-
vention and 114 patients for secondary prevention of sudden 
cardiac death. The two groups had largely similar clinical char-
acteristics, except significantly fewer inappropriate shock recip-
ients had prior coronary bypass surgery than nonrecipients (0 vs 
13.2%, P = 0.023). During the follow-up period, 5 (15.6%) and 
58 patients (50.0%) with an ICD for primary and secondary pre-
Table 1. Baseline patient characteristics
Variables
No  
Inappropriate  
Shock  
(n = 114)
Inappropriate  
Shock  
(n = 34)
P value
Age (yr) 53.0  
(40.8-65.0)
52.0  
(40.0-66.5)
0.975
Sex (male)   97 (85.1) 31 (91.2) 0.568
Diabetes mellitus   24 (21.1)   5 (14.7) 0.413
Hypertension   37 (32.5) 10 (29.4) 0.738
Current smoker   23 (20.2)   9 (26.5) 0.434
Previous PCI 11 (9.6)   4 (11.8) 0.749
Previous coronary bypass surgery   15 (13.2) 0 0.023
History of atrial fibrillation  10 (8.8) 10 (29.4) 0.004
QRS duration  > 0.12 sec   23 (20.2)   8 (23.5) 0.673
Left bundle branch block 11 (9.6) 2 (5.9) 0.733
Right bundle branch block   7 (6.1)   5 (14.7) 0.147
Left ventricular ejection fraction* 46.5  
(29.0-62.3)
54.5  
(31.8-63.0)
0.537
Serum creatinine (mg/dL) 0.98  
(0.80-1.14)
1.05  
(0.87-1.21)
0.153
Primary prevention   26 (22.8)   6 (17.6) 0.521
Etiology
   Ischemic cardiomyopathy
   Dilated cardiomyopathy
   Hypertrophic cardiomyopathy
   Idiopathic
   Others
 
  36 (31.6)
  18 (15.8)
  15 (13.2)
  35 (30.7)
10 (8.8)
 
  9 (26.5)
  5 (14.7)
  9 (26.5)
10 (29.4)
1 (2.9)
0.428
Device type
   Single chamber
   Dual chamber
 
107 (93.9)
  7 (6.1)
 
29 (85.3)
  5 (14.7)
0.108
Values are median with interquartile range or No. (%). Others = There were 6 Bruga-
da syndrome, 1 long QT syndrome, 1 arrhythmogenic right ventricle dysplasia, 1   
Ebstein anormaly, 1 valvular heart disease in no appropriate shock group and 1 ARVD 
in appropriate shock group. PCI, percutaneous coronary intervention; ARVD, arrhyth-
mogenic right ventricular dysplasia.Yang JH, et al.  •  Predictors and Clinical Impact of Inappropriate Shock
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vention, respectively, had an appropriate shock (P < 0.001). Six 
(18.8%) and 28 patients (24.1%) with an ICD for primary and sec-
ondary prevention, respectively, had an inappropriate shock 
(P = 0.521). Atrial fibrillation or atrial flutter was the most com-
mon cause of inappropriate shock (67.7%), followed by supra-
ventricular tachycardia including sinus tachycardia (23.5%), and 
then abnormal sensing (8.8%). Of these, two patients suffered 
inappropriate shocks because of T-wave oversensing and one 
patient experienced inappropriate shocks because of oversens-
ing due to noise. We analyzed the heart rate at the time of a pa-
tient’s first inappropriate shock for atrial fibrillation or atrial flut-
ter, and supraventricular tachycardia including sinus tachycar-
dia, but not for shocks due to abnormal sensing. The mean ven-
tricular rate that triggered inappropriate shock for atrial fibrilla-
tion or atrial flutter was 179 ± 28 beats/min, and for supraven-
tricular tachycardia including sinus tachycardia it was 172.4 ±  
23.2 beats/min.
Predictors of inappropriate shock and mortality during 
follow-up
Cox regression analysis was performed to identify predictors of 
inappropriate shock (Table 2). Sex, age  ≥ 70 yr, secondary pre-
vention, hypertrophic cardiomyopathy, use of beta-blocker, and 
interim appropriate shock did not influence inappropriate shock 
in the total patient population. The only significant univariate 
predictor of inappropriate shock was a history of atrial fibrilla-
tion. In the multivariate Cox regression model, the only inde-
pendent predictor of inappropriate shock was a history of atrial 
fibrillation. Cox regression analysis was also performed to rec-
ognize predictors of mortality (Table 3). Previous coronary by-
pass surgery, history of atrial fibrillation, serum creatinine  ≥ 1.5 
(mg/dL), interim appropriate shock, and interim inappropriate 
shock did not influence mortality in the total patient population. 
The significant univariate predictors of mortality were age  ≥ 70 yr 
and left ventricular ejection fraction  < 40%. In the multivariate 
Cox regression model, the independent predictors for mortality 
Table 2. Predictors of ≥ 1 inappropriate shocks 
Variables
Univariate Multivariate
Hazard ratio (95% CI) P value Hazard ratio (95% CI) P value
Male 0.64 (0.20-2.11) 0.438
Age  ≥ 70 yr 1.38 (0.60-3.18) 0.449 1.23 (0.52-2.91) 0.640
History of atrial fibrillation 3.94 (1.87-8.33) < 0.001 3.88 (1.69-8.90) 0.001
Secondary prevention  0.98 (0.40-2.39) 0.979
Hypertrophic cardiomyopathy 2.11 (0.98-4.54) 0.056 1.39 (0.61-3.20) 0.435
Beta-blocker 1.27 (0.55-2.92) 0.581 1.42 (0.58-3.47) 0.448
Interim appropriate shocks 0.76 (0.38-1.51) 0.426 0.68 (0.34-1.38) 0.289
Adjusted covariates include age  > 70 yr, history of atrial fibrillation, hypertrophic cardiomyopathy, use of beta-blocker at discharge, and interim appropriate shocks. CI, confi-
dence interval.
Table 3. Predictors of all-cause mortality 
Variables
Univariate Multivariate
Hazard ratio (95% CI) P value Hazard ratio (95% CI) P value
Age  ≥ 70 yr   8.09 (2.64-24.83) < 0.001 14.41 (3.11-66.76) 0.001
Previous coronary bypass surgery   2.91 (0.80-10.63) 0.106   5.60 (1.01-30.93) 0.048
History of atrial fibrillation 2.38 (0.64-8.82) 0.195   3.41 (0.75-15.59) 0.114
Left ventricular EF  < 40%   3.69 (1.13-12.04) 0.030 1.57 (0.36-6.79) 0.545
Serum creatinine  ≥ 1.5 (mg/dL) 3.27 (0.90-11.9) 0.072 0.69 (0.15-3.12) 0.628
Interim appropriate shock 2.29 (0.62-8.47) 0.215 1.35 (0.32-5.70) 0.685
Interim inappropriate shock 1.20 (0.37-3.91) 0.763 0.51 (0.12-2.18) 0.364
Adjusted covariates include age  > 70 yr, previous coronary bypass surgery, history of atrial fibrillation, left ventricular ejection fraction  < 40%, serum creatinine  ≥ 1.5 (mg/dL), 
interim appropriate shocks, interim inappropriate shock, and device type. CI, confidence interval; EF, ejection fraction.
Table 4. Clinical outcomes in inappropriate shock group compared with no inappropriate shock during follow-up period. 
Outcomes
No inappropriate  
shock (n = 114)
Inappropriate  
Shock (n = 34)
Unadjusted HR  
(95% CI)
P value
Adjusted HR*  
(95% CI)
P value
All-cause death 9 (7.9)   4 (11.8) 1.22 (0.37-3.95) 0.747 0.59 (0.14-2.45) 0.468
Cardiac-cause death 6 (5.3) 3 (8.8) 1.33 (0.33-5.32) 0.689 0.89 (0.13-6.20) 0.889
Cardiac-cause hospitalization 22 (19.3) 11 (32.4) 1.69 (0.82-3.50) 0.156 1.51 (0.62-3.67) 0.360
All-cause death or cardiac-cause hospitalization 29 (25.4) 12 (35.3) 1.35 (0.69-2.66) 0.386 1.06 (0.49-2.29) 0.877
Values are No. (%). *Adjusted covariates include age  > 70 yr, previous coronary bypass surgery, history of atrial fibrillation, left ventricular ejection fraction  < 40%, serum cre-
atinine  ≥ 1.5 (mg/dL), interim appropriate shocks, interim inappropriate shock, and device type. CI, confidence interval; HR, hazard ratio.Yang JH, et al.  •  Predictors and Clinical Impact of Inappropriate Shock
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were age  ≥ 70 yr and previous coronary bypass surgery.
Clinical outcomes
The median follow-up duration was 29 months (interquartile 
range: 8 to 53). Table 4 and Fig. 1 show the cumulative clinical 
outcomes of the study population during the follow-up period. 
The composite event of all-cause mortality or hospitalization 
for any cardiac cause was high in the inappropriate shock group, 
but the difference between groups was not statistically signifi-
cant (25.4% for no inappropriate shock vs 35.3% for inappropri-
ate shock, adjusted hazard ratio [HR]: 1.06, 95% confidence in-
terval [CI]: 0.49-2.29, P = 0.877). During the follow-up period, 
there were no significant differences between groups for all-
cause mortality (7.9% vs 11.8%, adjusted HR: 0.59, 95% CI: 0.14-
2.45, P = 0.468), death due to cardiac causes (5.3% vs 8.8%, ad-
justed HR: 0.89, 95% CI: 0.13-6.20, P = 0.889), and hospitaliza-
tion due to cardiac causes (19.3% vs 32.4%, adjusted HR: 1.51, 
95% CI: 0.62-3.67, P = 0.360). In patients implanted for second-
ary prevention, the incidences of combined all-cause mortality 
and hospitalization due to a cardiac cause, as well as all-cause 
mortality only between the two groups did not differ significantly 
(P = 0.412 for combined all-cause mortality or hospitalization 
due to a cardiac cause, P = 0.539 for all-cause mortality only).
DISCUSSION
We investigated the predictors and impacts of inappropriate 
shocks on long-term clinical outcome in patients implanted 
with an ICD for primary and secondary prevention of sudden 
cardiac death using a retrospective registry in Korea. The only 
predictor of inappropriate shock was a history of atrial fibrilla-
tion. Inappropriate shocks did not affect mortality and/or hospi-
talization for cardiac causes during the follow-up period, al-
though the incidence of inappropriate shocks was high. 
  Large-scale studies have estimated the incidence of inappro-
priate shock in patients implanted with an ICD to range from 
10% to 24% (8, 12-14). Similarly, 34 patients (23.0%) in our study 
experienced at least one inappropriate shock. Of these, 18 (52.9%) 
Fig. 1. Kaplan-Meier curves of inappropriate shock versus no inappropriate shock. (A) All-cause mortality in inappropriate shock (solid) versus no inappropriate shock (dashed). 
(B) A composite event of all-cause mortality or hospitalization for any cardiac reason in inappropriate shock versus no inappropriate shock. (C) All-cause mortality in inappropri-
ate shock versus no inappropriate shock in patients for second prevention of sudden cardiac death. (D) A composite event of all-cause mortality or hospitalization for any cardi-
ac reason in inappropriate shock versus no inappropriate shock in patients for second prevention of sudden cardiac death. 
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had experienced two or more inappropriate shocks. The most 
common cause of inappropriate shocks is atrial fibrillation or 
atrial flutter, and several studies have demonstrated that a his-
tory of atrial fibrillation is a consistent clinical predictor of inap-
propriate shock (12, 13, 15). Similarly, 66.7% of inappropriate 
shocks in our study were due to atrial fibrillation or atrial flutter. 
Additionally, multivariate analysis showed that a history of atri-
al fibrillation was the only significant predictor of inappropriate 
shocks. In contrast to previous studies, young age, the absence 
of coronary artery disease, and the use of beta-blockers were 
not predictors of inappropriate shocks in our study. In younger 
patients, inappropriate shocks were mainly caused by abnormal 
sensing and sinus tachycardia (16). In the current study, young 
age may not have been a predictor of inappropriate shock be-
cause only 8.8% patients had inappropriate shocks by abnormal 
sensing.
  Although the impact of inappropriate shock on clinical out-
come is unclear, it reduces quality of life due to pain and psy-
chological morbidity (17, 18). Strategies to reduce inappropri-
ate therapy using device programming rely on the ability to dis-
tinguish supraventricular and atrial arrhythmias from VT. Ad-
vanced algorithms, multiple sensing leads, and improved de-
vice programming should reduce the occurrence of inappropri-
ate shock (19-22). In this study, ICDs were reprogrammed in 15 
patients with an inappropriate shock. Of these, only one patient 
experienced additional inappropriate shocks. 
  In the Multicenter Automatic Defibrillator Implantation Trial-
II (MADIT-II), Daubert et al. (13) reported that increased mor-
tality in patients experiencing inappropriate shocks might be 
caused by adverse direct mechanical, arrhythmic, or hemody-
namic effects of the shocks themselves, such as fatal proarrhyth-
mia. In contrast to this and other reports (23, 24), inappropriate 
shocks had no impact on clinical outcome in our study. Dichtl 
et al. (8) also found that inappropriate shocks did not affect sur-
vival in a large number of patients with an ICD. Thus, further 
large-cohort studies with a long follow-up are needed to pro-
vide more accurate data on the relationship between inappro-
priate shock and clinical outcome.
  Our study has several limitations. First, it was nonrandomized, 
retrospective, and observational study, so confounding factors 
might have affected the results. Although we performed risk ad-
justments for potential confounding factors, we were not able 
to correct for unmeasured variables. Second, as all patients were 
from a single center, our observations and conclusions cannot 
necessarily be generalized. Third, the relatively small size of our 
study population may have influenced our results. Lastly, the 
relationship between inappropriate shocks and quality of life 
could not be assessed because quality of life data were not col-
lected.
  In conclusion, inappropriate shocks do not affect clinical out-
comes in ICD recipients, although the incidence of inappropri-
ate shocks is high, mainly due to atrial fibrillation. A long-term 
and large-scale randomized trial is needed to validate the clini-
cal findings in this study.
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